Vitamin trials and cancer: What went wrong?

Journal of Nutritional and Environmental Medicine

Volumn 8, Issue 3, 1998, Pages 277-288

  Ma, Carmen Wheatley ^a  

^a Caliban Scripts Ltd   (Switzerland)

Author keywords

Antioxidants; Cancer; Intervention; Nutrients; Treatment; Vitamin trials

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; RETINOL; VITAMIN;

ALCOHOL CONSUMPTION; CANCER; CANCER INCIDENCE; CANCER THERAPY; CIGARETTE SMOKING; HUMAN; LUNG CANCER; PRIORITY JOURNAL; REVIEW;

EID: 15444344411     PISSN: 13590847     EISSN: None     Source Type: Journal    
DOI: 10.1080/13590849862069     Document Type: Review

References (43)

1. Schwartz JL. The clinical control of tumour cell growth through the action of carotenoids, retinoids and tocopherols. Adjuvant Nutrition in Cancer Treatment, 1992 Symposium Proceedings, Arlington Heights IL: Cancer Treatment Research Foundation, 1993; 173-233.
2. Prasad KN, Edwards-Prasad J. Vitamin E and cancer prevention: recent advances and future potentials. J Am Coll Nut 1992; 11(5): 487-500.
3. Sporn MB, Roberts AB, Goodman DS, (Eds). The Retinoids, Biology, Chemistry and Medicine, 2nd edn. New York: Raven Press, 1994; 659.
4. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981; 290: 201-8.
5. Comstock GW, Bush TL, Helzsouer K. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992; 135: 115-21.
6. Waun KH, Itri LM. Retinoids and human cancer. In: Sporn ME, et al. eds. The Retinoids, 2nd edn. New York: Raven Press, 1994; 597-630.
7. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Eng J Med 1996; 334: 1145-49.
8. Blot WJ, Li L-J, Taylor PR, Guo W. et al. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J Nat Cancer Inst 1993; 85(18): 1483-91.
9. Omenn GS, Goodman GE, Thomquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. Nat Cancer Inst 1996; 88(21): 1550-9.
10. The ATBC Prevention Study Group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics and compliance. Ann Epidemiol 1994; 4(1): 1-10.
11. Li J-Y, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China; multiple vitamin/mineral supplementation cancer incidence, and disease-specific mortality among adults with oesophageal dysplasia. J Nat Canc Inst 1993; 85(18): 1492-8.
12. Goodman JE, Omenn GS, Thornquist MD, Lund B, et al. The carotene and retinol efficacy trial (CARET) to prevent lung cancer in high risk populations: pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 1993; 2(4): 389-96.
13. Stone LS, Papas AM. Tocopherols and the etiology of colon cancer. J Nat Cancer Inst 1997; 89(14): 1006-14.
14. Borek C. Antioxidants and cancer. Science and Med 1997; 4(6): 52-61.
15. Quillin P. An overview of the link between nutrition and cancer. In: Quillin P, Williams R, eds. Adjuvant Nutrition in Cancer Treatment. Arlington Heights, IL: Cancer Treatment Research Foundation, 1992.
16. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209-10.
17. Newton DE. Linus Pauling Scientist and Advocate. (Makers of Modern Science). New York: Facts on File Inc, 1994; 105-9.
18. Rose ML, Germolec D, Thurman RG. Dietary glycine completely prevents the increase in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Unpublished paper. Correspondence to: Dr Ronald Thurman, Laboratory of Hepatobiology and Toxicology, Dept. of Pharmacology, CB#7365, FLOB, University of North Carolina at Chapel Hill, NC 27599-7365, USA.
19. Helzslover KJ, Alberg AJ, Norkus EP, et al. Prospective study of serum micronutrients and ovarian cancer. J Nat Cancer Inst 1996; 88(1): 32-7.
20. Mayne ST, Handelman GJ, Beecher G. β-carotene and lung cancer promotion in heavy smokers - a plausible relationship? J Nat Cancer Inst 1996; 88(21): 1513-15.
21. Schwartz JL, Tanaka J, Khandekar V, et al. β-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells. Cancer Chemother Pharmacol 1992; 29: 207-13.
22. Bland J. The beta-carotene controversy in perspective. J Appl Nutr 1996; 48: 42-5.
23. Gudas LJ, Sporn MB, Roberts A. Cellular biology and biochemistry of the retinoids. In: Sporn MB et al., eds. The Retinoids 2nd edn. New York: Raven Press, 1994: 443-520.
24. Armstrong RB, Ashenfelter KO. General and reproductive toxicology of retinoids. In: Sporn MB et al., eds. The Retinoids 2nd edn. New York: Raven Press, 1994: 545-72.
25. Dennert G, Lotan R. Effects of retinoic acid on the immune system: stimulation of T killer cell induction. Eur J Immunol 1978; 8: 23-9.
26. Blomhoff K, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 1990; 250: 399-404.
27. Gerson M. A Cancer Therapy. Bonita, CA: Gerson Institute, 1990: 220, 418.
28. iegler RG, Colavito GA, Hartge P, et al. Importance of α-carotene, β-carotene and other phytochemicals in the etiology of lung cancer. J Nat Cancer Inst 1996; 88: 612-5.
29. Challem JJ. Beta-carotene and other carotcnoids: promises, failures, and a new vision. J Orthomolecular Med 1997; 12: 11-19.
30. Borek C. Vitamin E as an anti-carcinogen. Annal New York Acad Sci 1990; 570: 417-20.
31. Borek C, Ong A, Mason H, et al. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc Nat Acad Sci USA 1986; 83: 1490-4.
32. Rama BN, Prasad KN. Study on the specificity of alpha-tocopheryl (vitamin E) acid succinate effects on melanoma, glioma, and neuroblastoma cells in culture. Proc Soc Exp Biol Med 1983; 174: 302-7.
33. Toth B, Patil K. Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2-dimethylhydrazine dihydrochloride. J Nat Cancer Inst 1983; 70: 1107-11.
34. Xu X-C, Sozzi G, Lee JS, Pastorino U, et al. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J Nat Cancer Inst 1997; 89(9): 624-9.
35. Nervi C, Vollberg TM, George MD, et al. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp Cell Res 1991; 195: 163-70.
36. Mark SD. Defining and analysing cohorts using molecular markers of cancer risk. Cell Biochem 1996; 255: 69-79.
37. Cameron E, Pauling L. Cancer and Vitamin C. Philadelphia: Camino Books Inc, 1993: 117-18.
38. Holzman D. News: Researchers seek the role of antioxidants in apoplosis. J Nat Cancer Inst 1997; 89(6): 413-14.
39. Riordan Nil, Riordan HD, Meng X, et al. Intravenous ascorbate as a tumour cytotoxic chemotherapeutic agent. Medical Hypotheses 1995; 44: 207-13.
40. De Luca LM, Darwiche N, Jones CS, Scita G. Retinoids in differentiation and neoplasia. Science and Medicine 1995; 2(4): 28-37.
41. Campbell MJ, Koemer PH. Toward therapeutic intervention of cancer by vitamin D compounds. J Nat Cancer Inst 1997; 89(3): 182-5.
42. Lu X-P, Fanjul A, Picard N, et al. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nature Medicine 1997; 3(6): 686-90.
43. A comprehensive list of references covering these clinical trials can be obtained from: Novartis Nutrition GmbH, Werk Osthofen, Dr-Wander-strasse 11, D-67574 Osthofen, Switzerland.